Oxford accelerator proposes a new model for commercialising rare disease therapies

• The Therapeutics Accelerator (the ‘Accelerator’) will identify, fund and advance innovative projects from academic partners in the UK and US with the goal to deliver 40 new potentially life-changing therapies for rare diseases into clinical trials over the next ten years, targeting multiple approvals in key markets.
• The Accelerator will operate a unique non-profit/for-profit model with the intention to commit up to £200 million. 
• The Accelerator will receive support from a new partnership between University Hospitals in Cleveland, Ohio, University of Oxford and investment company Oxford Science Enterprises. 
• Former UK Prime Minister David Cameron to lead the international efforts of the Accelerator as Chair of the Oxford-Harrington Rare Disease Centre Advisory Board.

The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases :: Oxford-Harrington Rare Disease Centre (oxfordharrington.org)